Author:
Bonnefond Marie-Laure,Lambert Bernard,Giffard Florence,Abeilard Edwige,Brotin Emilie,Louis Marie-Hélène,Gueye Mor Sény,Gauduchon Pascal,Poulain Laurent,N’Diaye Monique
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Biochemistry (medical),Cell Biology,Clinical Biochemistry,Pharmaceutical Science,Pharmacology
Reference48 articles.
1. Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646–674
2. Juin P, Geneste O, Gautier F, Depil S, Campone M (2013) Decoding and unlocking the BCL-2 dependency of cancer cells. Nat Rev Cancer 13:455–465
3. Shigemasa K, Katoh O, Shiroyama Y et al (2002) Increased MCL-1 expression is associated with poor prognosis in ovarian carcinomas. Jpn J Cancer Res 93:542–550
4. Villedieu M, Louis MH, Dutoit S et al (2007) Absence of Bcl-xL down-regulation in response to cisplatin is associated with chemoresistance in ovarian carcinoma cells. Gynecol Oncol 105:31–44
5. Brotin E, Meryet-Figuiere M, Simonin K et al (2010) Bcl-XL and MCL-1 constitute pertinent targets in ovarian carcinoma and their concomitant inhibition is sufficient to induce apoptosis. Int.J. Cancer 126:885–895
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献